{
  "meta": {
    "trial_1_label": "placebo",
    "trial_1_text": "Clebopride  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Placebo Placebo: 40 participants will take placebo in the form of a capsule. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Clebopride. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Clebopride  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry.",
    "trial_2_label": "clebopride",
    "trial_2_text": "Clebopride  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Clebopride Supplement: 60 participants will take Clebopride 2000mg in the form of capsules daily. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Clebopride. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Clebopride  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry."
  },
  "AE": {
    "trial_1_ae": {
      "87": 0.2373237907886505,
      "78": 0.21977373957633972,
      "177": 0.14553485810756683,
      "17": 0.14175249636173248,
      "20": 0.1391942799091339,
      "123": 0.1368347406387329,
      "68": 0.13206738233566284,
      "46": 0.12261456996202469,
      "9": 0.1193147823214531,
      "49": 0.11397936940193176,
      "21": 0.11148945987224579,
      "37": 0.10550281405448914,
      "77": 0.10252515226602554,
      "189": 0.10218536853790283,
      "173": 0.1012495830655098,
      "67": 0.09647176414728165,
      "79": 0.09529580175876617,
      "200": 0.09413038194179535,
      "228": 0.08914657682180405,
      "188": 0.08765403926372528,
      "14": 0.0817318707704544,
      "29": 0.07641449570655823,
      "64": 0.07567456364631653,
      "350": 0.07490748912096024,
      "101": 0.07120444625616074,
      "180": 0.07052154839038849,
      "126": 0.06611710786819458,
      "2": 0.06569933146238327,
      "114": 0.06516706943511963,
      "239": 0.06128966808319092,
      "243": 0.06108938157558441,
      "104": 0.06084132939577103,
      "28": 0.060612063854932785,
      "27": 0.06030140072107315,
      "5": 0.0600893571972847,
      "179": 0.05871684476733208,
      "76": 0.05828970670700073,
      "193": 0.05800413340330124,
      "61": 0.055306851863861084,
      "86": 0.0545913502573967,
      "85": 0.054403167217969894,
      "147": 0.05080191045999527,
      "72": 0.048366088420152664,
      "151": 0.04835993051528931,
      "102": 0.04750259965658188,
      "122": 0.04708654806017876,
      "18": 0.04688834771513939,
      "194": 0.04494259133934975,
      "38": 0.04433920606970787,
      "261": 0.044157493859529495,
      "396": 0.04372620955109596,
      "82": 0.04354853183031082,
      "30": 0.043152499943971634,
      "131": 0.04252917319536209,
      "282": 0.0424506701529026,
      "116": 0.04224812984466553,
      "276": 0.042179252952337265,
      "96": 0.04110293462872505,
      "253": 0.040874775499105453,
      "164": 0.04083649814128876,
      "139": 0.04074534773826599,
      "35": 0.04003727808594704,
      "355": 0.03941325470805168,
      "69": 0.0392741858959198,
      "144": 0.03915446996688843,
      "191": 0.038719333708286285,
      "249": 0.03808801621198654,
      "269": 0.03803536295890808,
      "121": 0.03674419969320297,
      "288": 0.03615357354283333,
      "142": 0.035744808614254,
      "75": 0.03573726490139961,
      "286": 0.035312000662088394,
      "234": 0.03488229215145111,
      "262": 0.03435720130801201,
      "204": 0.03421282768249512,
      "466": 0.03351655602455139,
      "339": 0.03314468264579773,
      "186": 0.033125974237918854,
      "33": 0.032673534005880356,
      "441": 0.03228479251265526,
      "132": 0.032230112701654434,
      "130": 0.03177821636199951,
      "100": 0.03164348006248474,
      "163": 0.031578779220581055,
      "212": 0.03109958954155445,
      "31": 0.030806198716163635,
      "508": 0.03048109821975231,
      "92": 0.030203131958842278,
      "36": 0.03005746379494667,
      "211": 0.029873555526137352,
      "97": 0.02975333295762539,
      "153": 0.029601039364933968,
      "454": 0.02948801778256893,
      "382": 0.029273729771375656,
      "341": 0.029089882969856262,
      "154": 0.028820721432566643,
      "1": 0.028637506067752838,
      "256": 0.02853410318493843,
      "221": 0.028234342113137245
    },
    "trial_2_ae": {
      "87": 0.2373237907886505,
      "78": 0.21977373957633972,
      "177": 0.14553485810756683,
      "17": 0.14175249636173248,
      "20": 0.1391942799091339,
      "123": 0.1368347406387329,
      "68": 0.13206738233566284,
      "46": 0.12261456996202469,
      "9": 0.1193147823214531,
      "49": 0.11397936940193176,
      "21": 0.11148945987224579,
      "37": 0.10550281405448914,
      "77": 0.10252515226602554,
      "189": 0.10218536853790283,
      "173": 0.1012495830655098,
      "67": 0.09647176414728165,
      "79": 0.09529580175876617,
      "200": 0.09413038194179535,
      "228": 0.08914657682180405,
      "188": 0.08765403926372528,
      "14": 0.0817318707704544,
      "29": 0.07641449570655823,
      "64": 0.07567456364631653,
      "350": 0.07490748912096024,
      "101": 0.07120444625616074,
      "180": 0.07052154839038849,
      "126": 0.06611710786819458,
      "2": 0.06569933146238327,
      "114": 0.06516706943511963,
      "239": 0.06128966808319092,
      "243": 0.06108938157558441,
      "104": 0.06084132939577103,
      "28": 0.060612063854932785,
      "27": 0.06030140072107315,
      "5": 0.0600893571972847,
      "179": 0.05871684476733208,
      "76": 0.05828970670700073,
      "193": 0.05800413340330124,
      "61": 0.055306851863861084,
      "86": 0.0545913502573967,
      "85": 0.054403167217969894,
      "147": 0.05080191045999527,
      "72": 0.048366088420152664,
      "151": 0.04835993051528931,
      "102": 0.04750259965658188,
      "122": 0.04708654806017876,
      "18": 0.04688834771513939,
      "194": 0.04494259133934975,
      "38": 0.04433920606970787,
      "261": 0.044157493859529495,
      "396": 0.04372620955109596,
      "82": 0.04354853183031082,
      "30": 0.043152499943971634,
      "131": 0.04252917319536209,
      "282": 0.0424506701529026,
      "116": 0.04224812984466553,
      "276": 0.042179252952337265,
      "96": 0.04110293462872505,
      "253": 0.040874775499105453,
      "164": 0.04083649814128876,
      "139": 0.04074534773826599,
      "35": 0.04003727808594704,
      "355": 0.03941325470805168,
      "69": 0.0392741858959198,
      "144": 0.03915446996688843,
      "191": 0.038719333708286285,
      "249": 0.03808801621198654,
      "269": 0.03803536295890808,
      "121": 0.03674419969320297,
      "288": 0.03615357354283333,
      "142": 0.035744808614254,
      "75": 0.03573726490139961,
      "286": 0.035312000662088394,
      "234": 0.03488229215145111,
      "262": 0.03435720130801201,
      "204": 0.03421282768249512,
      "466": 0.03351655602455139,
      "339": 0.03314468264579773,
      "186": 0.033125974237918854,
      "33": 0.032673534005880356,
      "441": 0.03228479251265526,
      "132": 0.032230112701654434,
      "130": 0.03177821636199951,
      "100": 0.03164348006248474,
      "163": 0.031578779220581055,
      "212": 0.03109958954155445,
      "31": 0.030806198716163635,
      "508": 0.03048109821975231,
      "92": 0.030203131958842278,
      "36": 0.03005746379494667,
      "211": 0.029873555526137352,
      "97": 0.02975333295762539,
      "153": 0.029601039364933968,
      "454": 0.02948801778256893,
      "382": 0.029273729771375656,
      "341": 0.029089882969856262,
      "154": 0.028820721432566643,
      "1": 0.028637506067752838,
      "256": 0.02853410318493843,
      "221": 0.028234342113137245
    }
  },
  "safety": {
    "trial_1_safety": 0.30492791533470154,
    "trial_2_safety": 0.30492791533470154
  },
  "efficacy": {
    "prob_trial1_gt_trial2": 0.4791994094848633
  }
}